NEK2 and nonpapillary renal cell carcinoma: The aim was to evaluate the expression of NEK2, JMJD4, and REST in tissues of ccRCC and benign kidney to detect the relationship between their expression and clinical, pathological, prognostic, recurrence, and survival findings.